Kanka Pharmagen Private Limited
About Kanka Pharmagen Private Limited
Data last updated:
Kanka Pharmagen Private Limited is a private limited company based in Delhi, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 02 January 2023.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2023PTC409206.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Sudhir and Emma Romanovna Raimans.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Prop. No – 29 – D/2 – A Ground Floor Ward No – 1 Kh No1151/3 Desu Road Mehrauli, Delhi, India – 110030.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Kanka Pharmagen Private Limited's registered office is in Delhi, Delhi.
- Registered AddressProp. No – 29 – D/2 – A Ground Floor Ward No – 1 Kh No1151/3 Desu Road Mehrauli, Delhi, India – 110030
- IndustryTrading, Specialty, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Kanka Pharmagen Private Limited
FY 2024 filings availableFinancial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ||
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ||
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | ||
| Net Profit Margin | ||
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Kanka Pharmagen Private Limited, buy the company report.
Board of directors of Kanka Pharmagen Private Limited
Kanka Pharmagen has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sudhir Also directs: Digambara Security Private Limited | Director | 02 Jan 2023 | 3 Years 9 Months | Current |
| Emma Romanovna Raimans | Director | 05 Sep 2023 | 3 Years 1 Months | Current |
| Temuri Mamukashvili | Director | 28 Dec 2023 | 2 Years 10 Months | Current |
| Chavi Duggul Also directs: Digambara Security Private Limited | Director | 02 Jan 2023 | 3 Years 9 Months | Current |
Legal cases
No court or tribunal cases involving Kanka Pharmagen Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Kanka Pharmagen Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Kanka Pharmagen Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Kanka Pharmagen Private Limited has 6 board changes on record since 2023: 4 appointments and 2 cessations. The latest: Emma Romanovna Raimans ceased to be Additional Director on 29 Dec 2023.
Frequently asked questions
Kanka Pharmagen is an active private limited company based in Delhi, India. The company works in specialty, within the trading industry. It was incorporated on 02 January 2023 (3+ years old) and is registered under CIN U51909DL2023PTC409206.
Kanka Pharmagen has 4 current directors:
- Sudhir - Director
- Emma Romanovna Raimans - Director
- Temuri Mamukashvili - Director
- Chavi Duggul - Director
The latest financial statements of Kanka Pharmagen on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Kanka Pharmagen is U51909DL2023PTC409206. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kanka Pharmagen was incorporated on 02 January 2023, making it 3+ years old. It is registered with the Registrar of Companies, Delhi.
Emma Romanovna Raimans ceased to be Additional Director on 29 Dec 2023. Temuri Mamukashvili ceased to be Additional Director on 29 Dec 2023. Temuri Mamukashvili was appointed as Director on 28 Dec 2023. Kanka Pharmagen has 6 board changes on record in total.
The registered office of Kanka Pharmagen is at Prop. No – 29 – D2 – A Ground Floor Ward No – 1 Kh No11513 Desu Road Mehrauli, Delhi, India – 110030.
Kanka Pharmagen operates in the trading industry, in the specialty segment.
The compliance status of Kanka Pharmagen is compliant as of 16 July 2026. The company is actively filing with the Registrar of Companies.
Kanka Pharmagen can be reached at its registered office: Prop. No – 29 – D2 – A Ground Floor Ward No – 1 Kh No11513 Desu Road Mehrauli, Delhi, India – 110030.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
